Company Filing History:
Years Active: 1993
Title: Innovations of Lydia T So in Antihypertensive Compounds
Introduction
Lydia T So is a prominent inventor based in Maywood, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive compounds. With a total of 2 patents, her work has the potential to impact the treatment of hypertension and related conditions.
Latest Patents
Lydia's latest patents include innovative methods for creating antihypertensive compounds through fermentation processes. One notable patent describes the fermentation of the microorganism Streptomyces sp. MA6966 (ATCC 55293) in the presence of an Angiotensin II (A II) receptor antagonist. This process yields a new compound that is hydroxylated in the 2-butyl group, which serves as an A II antagonist useful in treating hypertension and congestive heart failure. Another patent focuses on the fermentation of Actinoplanes sp. MA6559 (ATCC 53771) under similar conditions, resulting in a compound with comparable therapeutic applications.
Career Highlights
Lydia T So is currently employed at Merck & Company, Inc., where she continues to advance her research in pharmacology. Her work is characterized by a commitment to developing effective treatments for cardiovascular diseases.
Collaborations
Lydia collaborates with esteemed colleagues such as Shieh-Shung T Chen and Raymond F White, contributing to a dynamic research environment that fosters innovation.
Conclusion
Lydia T So's contributions to the field of antihypertensive compounds exemplify her dedication to improving healthcare outcomes. Her innovative patents and collaborative efforts position her as a key figure in pharmaceutical research.